Floatz logo

VINDESINE

Adult T-cell Leukemia/Lymphoma

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

37 Active assets in the Adult T-cell Leukemia/Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
John Reneau
Phase 4BBB
DEXAMETHASONE
The First Affiliated Hospital of Soochow University
Phase 2BBB
Fludarabine
John Reneau
Phase 2BBB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BBB
cc-5013
National Cancer Institute (NCI)
Phase 2BBB

View all 50 →

Same molecule, other indications

VINDESINE is also rated in:

B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →